Company Update: BlackRock Inc (NYSE:BLK) – Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of BlackRock, Inc. (BLK)

[PR Newswire] – NEW YORK, June 24, 2016 /PRNewswire/ — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of BlackRock, Inc. and certain … Read more on this. BlackRock, Inc. (BLK) , valued at $55.49B, started trading this morning at $337.13. Looking at today’s market, BLK one day range is $335.06 to $343.88 and has traded between $275.00 and $369.33 over the past 12 months. BlackRock (BLK) shares are currently priced at 18.31x this year’s forecasted earnings, which makes them relatively expensive compared to the industry’s -53.33x earnings multiple for the same period. And for passive income investors, the company pays shareholders $9.16 per share annually in dividends, yielding 2.63%. In a review of the consensus earnings estimate this quarter, 16 sell-side analysts are looking at $4.84 per share, which would be $0.12 worse than the year-ago quarter and a $0.10 sequential increase. Investors should also note that the full-year EPS estimate of $19.49 is a $0.11 worse when compared to the previous year’s annual results. The quarterly earnings estimate is based on a consensus revenue forecast of the current quarter of $2.82 Billion. If realized, that would be a 2.76% decrease over the year-ago quarter. More recently, Citigroup upgraded BLK from Neutral to Buy (Apr 19, 2016). Previously, Gabelli & Co upgraded BLK from Hold to Buy. The average price target for BLK shares by the analysts covering the stock is $391.27, which is 16.06% above where the stock opened this morning. See more in (NYSE:BLK) Similar Articles: Market Update (NASDAQ:ALXN): SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Alexion Pharmaceuticals, Inc. (ALXN) Company Update (NYSE:BA): SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against The Boeing Company (BA) and Lead Plaintiff Deadline: April 22, 2016 Company Update (NYSE:FCX): SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Freeport-McMoRan Inc. (FCX)